Holden Stuart
SEC insider (Form 3/4/5 filer). CIK 0001763999. Director at UroGen Pharma Ltd. (URGN). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in PRINCETON, NJ.
Companies Holden Stuart has filed insider reports for
- UroGen Pharma Ltd. (URGN): Director
Holden Stuart
CIK: 0001763999
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
URGN
UroGen Pharma Ltd.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 22, 2026URGN
UroGen Pharma Ltd.
AwardDirectStock Option (right ot buy)
20K shares- - Nov 26, 2025URGN
UroGen Pharma Ltd.
ExerciseDirect2K shares- - Aug 26, 2025URGN
UroGen Pharma Ltd.
AwardDirectStock Option (right ot buy)
10K shares- - Aug 26, 2025URGN
UroGen Pharma Ltd.
AwardDirectRestricted Stock Unit
8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 | URGN UroGen Pharma Ltd. | Award Stock Option (right ot buy) | 20,000 | - | - | Direct |
| Nov 26, 2025 | URGN UroGen Pharma Ltd. | Exercise | 2,000 | - | - | Direct |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | Award Stock Option (right ot buy) | 10,000 | - | - | Direct |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | Award Restricted Stock Unit | 8,000 | - | - | Direct |
1-4 of 4 transactions